Even though activation of immunity is associated with bone destruction, new mechanisms have been described in 2014 through which immunology-associated pathways can cooperate to support osteogenesis.

A group of Dallas doctors and scientists have printed a human femur — the longest and strongest bone in the body — that ...

Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a ...

Therefore, Erez and her team treated mice with TNBC bone metastasis with an antibody targeting the development of G-MDSCs (anti-IL1β) with an immune checkpoint inhibitor (anti-TIGIT). The combination ...

Instead of using a patient's own bone or titanium to repair skull fractures, researchers are working on using artificial ...

The pharmaceutical firm has touted its ambition to become an immunology powerhouse, and earlier this year it clinched a pact to buy a promising antibody drug for up to $1.9 billion.

Program in Immunology investigators at Fred Hutch are learning how immune cells respond to disease and how to safely enhance immune responses to better control, ... also developed to prevent the graft ...

A bone marrow or blood stem cell transplant has been an effective but risky way to treat multiple sclerosis (MS) for a few patients, and now researchers know more about why the treatment can reduce ...

The program is shared between the Sections of Immunology, Allergy and Rheumatology in the Departments of Pediatrics and Medicine at Baylor College of Medicine. Track (Department of Medicine) Medicine ...

Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib.